Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

621 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study.
Valerio L, Mavromanoli AC, Barco S, Abele C, Becker D, Bruch L, Ewert R, Faehling M, Fistera D, Gerhardt F, Ghofrani HA, Grgic A, Grünig E, Halank M, Held M, Hobohm L, Hoeper MM, Klok FA, Lankeit M, Leuchte HH, Martin N, Mayer E, Meyer FJ, Neurohr C, Opitz C, Schmidt KH, Seyfarth HJ, Wachter R, Wilkens H, Wild PS, Konstantinides SV, Rosenkranz S; FOCUS Investigators. Valerio L, et al. Among authors: rosenkranz s. Eur Heart J. 2022 Sep 21;43(36):3387-3398. doi: 10.1093/eurheartj/ehac206. Eur Heart J. 2022. PMID: 35484821 Free PMC article.
[Imatinib for pulmonary arterial hypertension].
Hoeper MM, Opitz C, Olschewski H, Ulrich S, Speich R, Behr J, Halank M, Wilkens H, Klose H, Lange TJ, Grünig E, Seeger W, Ewert R, Borst MM, Welte T, Rosenkranz S, Ghofrani HA. Hoeper MM, et al. Among authors: rosenkranz s. Dtsch Med Wochenschr. 2014 Dec;139 Suppl 4:S151-4. doi: 10.1055/s-0034-1387457. Epub 2014 Dec 9. Dtsch Med Wochenschr. 2014. PMID: 25489685 Review. German. No abstract available.
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial.
Hoeper MM, Al-Hiti H, Benza RL, Chang SA, Corris PA, Gibbs JSR, Grünig E, Jansa P, Klinger JR, Langleben D, McLaughlin VV, Meyer GMB, Ota-Arakaki J, Peacock AJ, Pulido T, Rosenkranz S, Vizza CD, Vonk-Noordegraaf A, White RJ, Chang M, Kleinjung F, Meier C, Paraschin K, Ghofrani HA, Simonneau G; REPLACE investigators. Hoeper MM, et al. Among authors: rosenkranz s. Lancet Respir Med. 2021 Jun;9(6):573-584. doi: 10.1016/S2213-2600(20)30532-4. Epub 2021 Mar 24. Lancet Respir Med. 2021. PMID: 33773120 Clinical Trial.
Cologne Consensus Conference on pulmonary hypertension.
Rosenkranz S, Ghofrani HA, Grünig E, Hoeper MM. Rosenkranz S, et al. Int J Cardiol. 2011 Dec;154 Suppl 1:S1-2. doi: 10.1016/S0167-5273(11)70487-9. Int J Cardiol. 2011. PMID: 22221968 No abstract available.
[Riociguat: stimulator of soluble guanylate-cyclase. New mode of action for the treatment of pulmonary arterial and non operable chronic thromboembolic pulmonary hypertension].
Leuchte HH, Behr J, Ewert R, Ghofrani HA, Grünig E, Halank M, Held M, Klose H, Rosenkranz S, Schermuly RT, Wilkens H, Hoeper MM. Leuchte HH, et al. Among authors: rosenkranz s. Pneumologie. 2015 Mar;69(3):135-43. doi: 10.1055/s-0034-1391435. Epub 2015 Mar 6. Pneumologie. 2015. PMID: 25750094 Free article. Review. German.
Treatment of pulmonary arterial hypertension (PAH): updated Recommendations of the Cologne Consensus Conference 2011.
Ghofrani HA, Distler O, Gerhardt F, Gorenflo M, Grünig E, Haefeli WE, Held M, Hoeper MM, Kähler CM, Kaemmerer H, Klose H, Köllner V, Kopp B, Mebus S, Meyer A, Miera O, Pittrow D, Riemekasten G, Rosenkranz S, Schranz D, Voswinckel R, Olschewski H. Ghofrani HA, et al. Among authors: rosenkranz s. Int J Cardiol. 2011 Dec;154 Suppl 1:S20-33. doi: 10.1016/S0167-5273(11)70490-9. Int J Cardiol. 2011. PMID: 22221970 Free article.
[Right heart catheterization in pulmonary hypertension].
Rosenkranz S, Behr J, Ewert R, Ghofrani HA, Grünig E, Halank M, Hoeper MM, Leuchte HH, Olschewski H, Schmeisser A, Speich R, Wilkens H, Opitz CF. Rosenkranz S, et al. Dtsch Med Wochenschr. 2011 Dec;136(50):2601-16; quiz 2617-20. doi: 10.1055/s-0031-1292858. Epub 2011 Dec 7. Dtsch Med Wochenschr. 2011. PMID: 22160954 Review. German. No abstract available.
[Targeted therapy of pulmonary arterial hypertension (PAH)].
Klose H, Opitz C, Bremer H, Ewert R, Bonderman D, Rosenkranz S, Seeger W, Schmeißer A, Harbaum L, Buerke M, Ghofrani HA, Borst MM, Leuchte HH, Lange TJ, Behr J, Ulrich S, Lang I, Olschewski H, Gall H, Kabitz HJ, Kleber FX, Held M, Hoeper MM, Grünig E. Klose H, et al. Among authors: rosenkranz s. Dtsch Med Wochenschr. 2014 Dec;139 Suppl 4:S142-50. doi: 10.1055/s-0034-1387489. Epub 2014 Dec 9. Dtsch Med Wochenschr. 2014. PMID: 25489684 Review. German. No abstract available.
621 results